Investors Snag AIMT Even Cheaper Than Its Secondary Stock Offering
February 23, 2018 at 10:53 AM EST
Looking back to 2 days ago, Aimmune Therapeutics Inc (AIMT) priced a 5,500,000 share secondary stock offering at $32.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..